The Czechoslovak Group (CSG) is heading into its first quarterly report as a public company with a stark disconnect between its financial health and market reception. While the defence contractor’s order book has swelled to record levels and all nine covering analysts rate the stock a buy, the share price has tumbled roughly 53% from its January peak, touching a fresh 52-week low of €15.73 on Friday.
The sell-off accelerated after short-seller Hunterbrook published a critical report earlier this week, sending the stock down nearly 19% in a single session on Tradegate to €15.20. The attack came during a mandatory quiet period that began in late April, leaving management unable to respond publicly until the May 20 earnings release.
A Tale of Two Markets
The gulf between CSG’s operational performance and its stock price is hard to ignore. The company closed 2025 with revenue up nearly 72% to €6.74 billion and an adjusted operating EBIT margin of 24.1%. Management has guided for 2026 revenue between €7.4 billion and €7.6 billion, with margins expected to improve to 24-25% and a medium-term target of 26-28%.
The order backlog has ballooned to over €15 billion, while the broader pipeline — including potential new armoured vehicle contracts — now stands at €42 billion, up from €32 billion previously. The company’s own production is set to expand roughly 20% this year, with a new Slovak manufacturing line adding 70,000 additional units.
Yet the stock languishes at around €16.15, a far cry from its 52-week high of €35.50. The average analyst price target of €35.40 implies more than 100% upside from current levels, with the most bullish forecast hitting €42.
Rating Agencies and New Contracts
The operational strength has not gone unnoticed by credit rating agencies. In February, Moody’s upgraded CSG’s secured debt from Ba1 to Baa3, lifting it from speculative to investment grade. Fitch affirmed its BBB- rating with a stable outlook, citing improved governance and a more conservative financial strategy.
New business continues to flow in. In April, CSG secured a contract worth nearly €250 million to supply 155mm artillery ammunition to a European customer. In Azerbaijan, a subsidiary launched the VEXA DS joint venture, a ten-year programme for armoured vehicle maintenance and modernisation valued in the hundreds of millions.
Should investors sell immediately? Or is it worth buying CSG?
At the end of March, CSG announced the acquisition of a 49% stake in Austrian munitions specialist Hirtenberger Defence Systems, pending regulatory approval — a decision that could serve as a near-term catalyst.
The €275 Million Question
One overhang that has now been resolved: a €275 million receivable that had drawn scrutiny was fully paid off in the first quarter. The company’s net debt is expected to decline to 0.7 times EBITDA by the end of 2026, according to JPMorgan analyst David Perry, who called CSG “particularly attractive” within the European defence sector.
But the immediate focus for investors will be the May 20 report, which will reveal IPO-related costs incurred after year-end that are expected to weigh on first-quarter 2026 results. The 30-day volatility reading of over 66% underscores just how jittery the market has become.
Geopolitical Headwinds
Beyond the short-seller attack, broader concerns about a potential ceasefire in Ukraine have weighed on sentiment. Some market participants worry that an end to hostilities could cool the defence spending cycle that has fuelled CSG’s rapid growth.
The company, however, continues to diversify. Recent wins include a framework agreement with Polish conglomerate PGZ for drone propulsion and missiles, plus air defence contracts in Southeast Asia worth $2.5 billion.
With nine analysts unanimously bullish and the stock trading at a fraction of their price targets, the May 20 earnings release represents a critical test. Whether the numbers can break the silence and reverse the selling pressure remains to be seen.
Ad
CSG Stock: Buy or Sell?! New CSG Analysis from May 8 delivers the answer:
The latest CSG figures speak for themselves: Urgent action needed for CSG investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from May 8.
CSG: Buy or sell? Read more here...
